Intellia Therapeutics, Inc. (NTLA)

NASDAQ: NTLA · Real-Time Price · USD

10.73

-0.37 (-3.33%)

At close: Jul 24, 2026, 4:00 PM EDT

10.94

+0.21 (1.96%)

Pre-market: Jul 27, 2026, 7:01 AM EDT

Intellia Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	134.7	155.46	189.18	226.75	523.51	123.41
Short-Term Investments	241.29	294.42	412.33	685.48	669.12	625.28
Cash & Short-Term Investments	375.99	449.88	601.52	912.22	1,193	748.69
Cash Growth	-25.36%	-25.21%	-34.06%	-23.51%	59.29%	25.33%
Accounts Receivable	9.13	9.47	8.52	36.46	3.77	2.03
Other Current Assets	81.33	68.36	29.83	49.65	20.41	18.58
Total Current Assets	466.45	527.71	639.86	998.33	1,217	769.3
Net Property, Plant & Equipment	113.06	123.63	246.67	148.14	161	100.11
Long-Term Investments	141.26	155.25	260.22	111.63	101.79	395.49
Other Long-Term Assets	38.01	35.54	44.26	42.88	40.53	29.56
Total Assets	758.78	842.13	1,191	1,301	1,520	1,294

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	18.8	20.25	14.59	7.45	5.15	9.65
Accrued Expenses	37.92	49.86	55.36	67.02	60.88	43.31
Current Portion of Leases	19.1	26.48	20.25	18.6	16.69	9.11
Unearned Revenue	0.63	7.29	20.66	22.14	43.84	63.76
Total Current Liabilities	76.45	103.88	110.85	115.21	126.55	125.83
Long-Term Leases	61.4	66.85	189.95	96.75	114.02	64.91
Other Long-Term Liabilities	-	-	18.26	38.85	43.96	63.48
Total Long-Term Liabilities	61.4	66.85	208.21	135.6	157.98	-125.83
Total Liabilities	137.84	170.73	319.06	250.81	284.53	0

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-in Capital	3,307	3,260	3,049	2,711	2,420	1,746
Accumulated Other Comprehensive Income	-0.24	1.03	0.61	-2.26	-7.46	-2.63
Retained Earnings	-2,686	-2,590	-2,177	-1,658	-1,177	-703
Shareholders' Equity	620.94	671.39	871.96	1,050	1,236	1,040
Total Liabilities & Equity	758.78	842.13	1,191	1,301	1,520	1,294

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	80.49	93.33	210.2	115.35	130.7	74.02
Net Cash (Debt)	295.5	356.56	391.32	796.88	1,062	674.67
Net Cash Growth	-23.15%	-8.88%	-50.89%	-24.96%	57.40%	20.89%
Net Cash Per Share	2.64	3.29	3.96	8.98	13.80	9.52
Book Value	620.94	671.39	871.96	1,050	1,236	1,040
Book Value Per Share	5.54	6.20	8.82	11.83	16.05	14.67
Tangible Book Value	620.94	671.39	871.96	1,050	1,236	1,040
Tangible Book Value Per Share	5.54	6.20	8.82	11.83	16.05	14.67

SEC Filings: 10-K · 10-Q